Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

The importance of BRCA1 and BRCA2 genes mutations in breast cancer development.

Mehrgou A, Akouchekian M.

Med J Islam Repub Iran. 2016 May 15;30:369. eCollection 2016. Review.

2.

Polygenic risk score is associated with increased disease risk in 52 Finnish breast cancer families.

Muranen TA, Mavaddat N, Khan S, Fagerholm R, Pelttari L, Lee A, Aittomäki K, Blomqvist C, Easton DF, Nevanlinna H.

Breast Cancer Res Treat. 2016 Aug;158(3):463-9. doi: 10.1007/s10549-016-3897-6. Epub 2016 Jul 20.

3.

The Activities and Impact of State Programs to Address Hereditary Breast and Ovarian Cancer, 2011-2014.

Trivers KF, Rodriguez JL, Cox SL, Crane BE, Duquette D.

Healthcare (Basel). 2015 Oct 15;3(4):948-63. doi: 10.3390/healthcare3040948.

4.

Importance of hereditary and selected environmental risk factors in the etiology of inflammatory breast cancer: a case-comparison study.

Moslehi R, Freedman E, Zeinomar N, Veneroso C, Levine PH.

BMC Cancer. 2016 May 26;16:334. doi: 10.1186/s12885-016-2369-z.

5.

Assessing biases of information contained in pedigrees for the classification of BRCA-genetic variants: a study arising from the ENIGMA analytical working group.

Kerkhofs CH, Spurdle AB, Lindsey PJ, Goldgar DE, Gómez-García EB.

Hered Cancer Clin Pract. 2016 Apr 30;14:10. doi: 10.1186/s13053-016-0050-9. eCollection 2016.

6.

Prediction of Cancer Prevention: From Mammogram Screening to Identification of BRCA1/2 Mutation Carriers in Underserved Populations.

Robinson LS, Hendrix A, Xie XJ, Yan J, Pirzadeh-Miller S, Pritzlaff M, Read P, Pass S, Euhus D, Ross TS.

EBioMedicine. 2015 Oct 21;2(11):1827-33. doi: 10.1016/j.ebiom.2015.10.022. eCollection 2015 Nov.

7.

A steroid metabolizing gene variant in a polyfactorial model improves risk prediction in a high incidence breast cancer population.

Jupe ER, Dalessandri KM, Mulvihill JJ, Miike R, Knowlton NS, Pugh TW, Zhao LP, DeFreese DC, Manjeshwar S, Gramling BA, Wiencke JK, Benz CC.

BBA Clin. 2014 Nov 8;2:94-102. doi: 10.1016/j.bbacli.2014.11.001. eCollection 2014 Dec.

8.

Bias Correction Methods Explain Much of the Variation Seen in Breast Cancer Risks of BRCA1/2 Mutation Carriers.

Vos JR, Hsu L, Brohet RM, Mourits MJ, de Vries J, Malone KE, Oosterwijk JC, de Bock GH.

J Clin Oncol. 2015 Aug 10;33(23):2553-62. doi: 10.1200/JCO.2014.59.0463. Epub 2015 Jul 6. Review.

9.

A risk prediction algorithm for ovarian cancer incorporating BRCA1, BRCA2, common alleles and other familial effects.

Jervis S, Song H, Lee A, Dicks E, Harrington P, Baynes C, Manchanda R, Easton DF, Jacobs I, Pharoah PP, Antoniou AC.

J Med Genet. 2015 Jul;52(7):465-75. doi: 10.1136/jmedgenet-2015-103077. Epub 2015 May 29.

10.

Recent Enhancements to the Genetic Risk Prediction Model BRCAPRO.

Mazzola E, Blackford A, Parmigiani G, Biswas S.

Cancer Inform. 2015 May 10;14(Suppl 2):147-57. doi: 10.4137/CIN.S17292. eCollection 2015. Review.

11.

Practical problems with clinical guidelines for breast cancer prevention based on remaining lifetime risk.

Quante AS, Whittemore AS, Shriver T, Hopper JL, Strauch K, Terry MB.

J Natl Cancer Inst. 2015 May 8;107(7). pii: djv124. doi: 10.1093/jnci/djv124. Print 2015 Jul.

12.

The CHEK2 1100delC allelic variant is not present in familial and sporadic breast cancer cases from Moroccan population.

Marouf C, Hajji O, Diakité B, Tazzite A, Jouhadi H, Benider A, Nadifi S.

Springerplus. 2015 Feb 1;4:38. doi: 10.1186/s40064-014-0778-5. eCollection 2015.

13.

Genetic variation in cell cycle regulatory gene AURKA and association with intrinsic breast cancer subtype.

Taylor NJ, Bensen JT, Poole C, Troester MA, Gammon MD, Luo J, Millikan RC, Olshan AF.

Mol Carcinog. 2015 Dec;54(12):1668-77. doi: 10.1002/mc.22238. Epub 2014 Oct 18.

14.

The impact of reporting incidental findings from exome and whole-genome sequencing: predicted frequencies based on modeling.

Ding LE, Burnett L, Chesher D.

Genet Med. 2015 Mar;17(3):197-204. doi: 10.1038/gim.2014.94. Epub 2014 Jul 31.

15.

Breast cancer risk assessment using genetic variants and risk factors in a Singapore Chinese population.

Lee CP, Irwanto A, Salim A, Yuan JM, Liu J, Koh WP, Hartman M.

Breast Cancer Res. 2014 Jun 18;16(3):R64. doi: 10.1186/bcr3678.

16.

Frequent germline deleterious mutations in DNA repair genes in familial prostate cancer cases are associated with advanced disease.

Leongamornlert D, Saunders E, Dadaev T, Tymrakiewicz M, Goh C, Jugurnauth-Little S, Kozarewa I, Fenwick K, Assiotis I, Barrowdale D, Govindasami K, Guy M, Sawyer E, Wilkinson R; UKGPCS Collaborators, Antoniou AC, Eeles R, Kote-Jarai Z.

Br J Cancer. 2014 Mar 18;110(6):1663-72. doi: 10.1038/bjc.2014.30. Epub 2014 Feb 20.

17.

Estimating risks for variants of unknown significance according to their predicted pathogenicity classes with application to BRCA1.

Dowty JG, Lee E, McKean-Cowdin R, Henderson BE, Bernstein L, Ursin G, Hopper JL.

Breast Cancer Res Treat. 2014 Feb;144(1):171-7. doi: 10.1007/s10549-014-2845-6. Epub 2014 Jan 31.

18.

Comparison of mRNA splicing assay protocols across multiple laboratories: recommendations for best practice in standardized clinical testing.

Whiley PJ, de la Hoya M, Thomassen M, Becker A, Brandão R, Pedersen IS, Montagna M, Menéndez M, Quiles F, Gutiérrez-Enríquez S, De Leeneer K, Tenés A, Montalban G, Tserpelis D, Yoshimatsu T, Tirapo C, Raponi M, Caldes T, Blanco A, Santamariña M, Guidugli L, de Garibay GR, Wong M, Tancredi M, Fachal L, Ding YC, Kruse T, Lattimore V, Kwong A, Chan TL, Colombo M, De Vecchi G, Caligo M, Baralle D, Lázaro C, Couch F, Radice P, Southey MC, Neuhausen S, Houdayer C, Fackenthal J, Hansen TV, Vega A, Diez O, Blok R, Claes K, Wappenschmidt B, Walker L, Spurdle AB, Brown MA; ENIGMA consortium.

Clin Chem. 2014 Feb;60(2):341-52. doi: 10.1373/clinchem.2013.210658. Epub 2013 Nov 8.

19.

Quantitative assessment of common genetic variants on chromosome 5p12 and hormone receptor status with breast cancer risk.

Yu Y, Chen Z, Wang H, Zhang Y.

PLoS One. 2013 Aug 19;8(8):e72154. doi: 10.1371/journal.pone.0072154. eCollection 2013.

20.

Breast cancer in the young: role of the geneticist.

Woodson AH, Profato JL, Muse KI, Litton JK.

J Thorac Dis. 2013 Jun;5 Suppl 1:S19-26. doi: 10.3978/j.issn.2072-1439.2013.04.13.

Items per page

Supplemental Content

Write to the Help Desk